Shreyaskumar Patel

Shreyaskumar Patel is a Professor of Medicine at The University of Texas MD Anderson Cancer Center, specializing in sarcoma oncology, surgical oncology, and cancer pharmacology. His research focuses on rare soft tissue and bone tumors, including synovial sarcoma, dedifferentiated liposarcoma, and rhabdomyosarcoma, with recent work exploring immune checkpoint blockade and antibody-drug conjugates for metastatic disease. He has published extensively on novel therapeutic combinations, including ziftomenib with imatinib for advanced gastrointestinal stromal tumors, and has contributed to the pathological characterization of deceptive thyroid malignancies. His international collaborations and leadership in sarcoma clinical trials have established him as a leading figure in cancer research and treatment.